GLR-1062

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameGLR-1062
Drug Alias NameGLR1062GLR-1062
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionAnti-Vascular endothelial growth factor
TargetsVascular endothelial growth factor
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGan & Lee Pharmaceuticals
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGan & Lee Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A